Everolimus - Moligand™, ≥98% , FK506-binding protein 1A inhibitor, CAS No.159351-69-6, FK506-binding protein 1A inhibitor
Disponible
SKU
E125341
Potent mTOR inhibitor
Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.
An immunosuppresive inhibitor of FRAP (mTOR).
Más Información
| CAS | 159351-69-6 |
|---|---|
| Sinónimos | EVEROLIMUS (USP-RS) | EVEROLIMUS [MI] | Votubia | 5-methyl-5-phenyl-barbituric acid | DTXCID8020599 | EVEROLIMUS [VANDF] | Everolimus tablets | RAD, SDZ | AKOS015907063 | L04AA18 | SDZ RAD | UNII-9HW64Q8G6G | Tox21_112510 | (3S,6R,7E,9R,10R,12R,14S,15E,17 |
| Especificaciones y pureza | Moligand™, ≥98% |
| Condiciones de almacenamiento de almacenamiento | Store at -20°C |
| Enviado en | Ice chest + Ice pads |
| Product Description | Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM. |
| Pubchem Sid | 488195795 |
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488195795 |
| Solubilidad | Soluble in chloroform, methanol, DMSO (100 mg/ml), water (<1 mg/ml at 25 °C), and ethanol (100 mg/ml). |
| Objetivo | MTOR |
| Número CE | 621-003-9 |
| PubChem CID | 6442177 |
| Fórmula molecular | C53H83NO14 |
Reseñas
Reseñas de cliente
¡Hemos encontrado otros productos que te pueden gustar!
-
Everolimus (RAD001), FK506-binding protein 1A inhibitorDesde 49,90 US$
Remind me later